Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 22;9(1):e001642. doi: 10.1136/jitc-2020-001642

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Characterization of primary tumor and genomic subtypes of patients with melanoma. (A) Primary tumor type of the entire cohort of 230 individual patients was analyzed. Our cohort was comprised of 171 (74%) cutaneous, 25 (11%) mucosal, 19 (8%) unknown primary and 15 (7%) acral melanoma patients, respectively. (B) Within the entire cohort, 86 (37%) of patients were BRAF/NRAS wild-type (WT), 80 (35%) had BRAF V600E/K mutations and 64 (28%) had NRAS mutations. (C) The incidence of genomic subtypes according to primary tumor type is indicated.